| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |